Mov­ing be­yond just sol­id dose, Re­cro Phar­ma is head­ed to San Diego with ac­qui­si­tion

Penn­syl­va­nia-based CD­MO Re­cro Phar­ma is ex­pand­ing to the West Coast with the ac­qui­si­tion of Irisys, a San Diego CD­MO.

The com­pa­ny an­nounced the deal Fri­day. Re­cro bought Irisys for about $50 mil­lion in cash, shares and a promis­so­ry note.

Irisys can com­mer­cial­ly man­u­fac­ture oral liq­uids, ster­ile in­jecta­bles, tablets, top­i­cals, liq­uid- and pow­der-filled cap­sules, oph­thalmic drop­pers, li­po­somes, and nanopar­ti­cles. With the ac­qui­si­tion, Re­cro gets al­most 40 clients in six coun­tries around the world.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER